Therapeutic Drug Monitoring Market worth 2.55 Billion USD by 2020 - PowerPoint PPT Presentation

Loading...

PPT – Therapeutic Drug Monitoring Market worth 2.55 Billion USD by 2020 PowerPoint presentation | free to download - id: 80aa2a-OGMzO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Therapeutic Drug Monitoring Market worth 2.55 Billion USD by 2020

Description:

The therapeutic drug Monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 Billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020). – PowerPoint PPT presentation

Number of Views:14
Updated: 11 April 2016
Slides: 13
Provided by: mmmwaterman

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Therapeutic Drug Monitoring Market worth 2.55 Billion USD by 2020


1
MarketsandMarkets Presents
Therapeutic Drug Monitoring Market worth 2.55
Billion USD by 2020
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
2
The report "Therapeutic Drug Monitoring Market by
Product (Consumables, Equipment), Technology
(Immunoassays, Proteomic Technologies), Class of
Drug (Antiepileptics, Antibiotics,
Immunosuppressants), End User (Hospital Labs,
Private Labs) - Global Forecast to 2020", The
therapeutic drug monitoring market is projected
to reach USD 2.55 Billion by 2020 from USD 1.78
Billion in 2015, growing at a CAGR of 7.4 during
the forecast period (20152020). Browse 80
tables and 55 figures spread through 142 Pages
and in-depth TOC on "Therapeutic Drug Monitoring
Market by Product (Consumables, Equipment),
Technology (Immunoassays, Proteomic
Technologies), Class of Drug (Antiepileptics,
Antibiotics, Immunosuppressants), End User
(Hospital Labs, Private Labs) - Global Forecast
to 2020" http//www.marketsandmarkets.com/Market-
Reports/therapeutic-drug-monitoring-market-1553504
43.html
 
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
3
Early buyers will receive 10 customization on
this report.

 
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
4
  • This report provides a detailed overview of the
    major drivers, restraints, challenges,
    opportunities, current market trends, and
    strategies impacting the therapeutic drug
    monitoring market along with the estimates and
    forecasts of the revenue.


http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
5
  • The technological advances in tests used to
    monitor therapeutic drugs, increased knowledge of
    pharmacogenetics and pharmacokinetics of drugs,
    need for better healthcare in developing
    countries, and rising prevalence of psychiatric
    diseases and cancer are the major drivers for the
    therapeutic drug monitoring market. Adjunct
    technologies such as biomarker identification
    using proteomics to accurately identify clinical
    outcomes and genetic testing are expected to
    benefit the growth of the therapeutic drug
    monitoring market. However, high infrastructure
    costs and dearth of skilled resources may
    restrain the market growth.


http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
6
  • In this report, the therapeutic drug monitoring
    market is broadly segmented by product,
    technology, class of drug, end user, and region.
    On the basis of product, the therapeutic drug
    monitoring market is divided into consumables and
    equipment. The equipment segment is further
    segmented into immunoassay analyzers, proteomic
    equipment, and other equipment.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
7
  • On the basis of technology, the therapeutic drug
    monitoring market is categorized into three
    segments namely, immunoassays, proteomic
    technologies, and others. The immunoassays
    segment is classified into chemiluminescent assay
    (CLIA), cloned enzyme donor immunoassay (CEDIA),
    fluorescence polarization immunoassay (FPIA),
    particle-enhanced turbidimetric inhibition
    immunoassay (PETINIA), and others. The proteomic
    technologies segment is further split into liquid
    chromatography/mass spectrometry and gas
    chromatography/mass spectrometry.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
8
  • On the basis of class of drug, the therapeutic
    drug monitoring market is segmented into
    antiepileptics, antibiotics, immunosuppressants,
    antiarrhythmic drugs, bronchodilators,
    psychoactive drugs, and others. By end user, the
    therapeutic drug monitoring market is segmented
    into hospital labs, commercial/private labs, and
    other end users.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
9
  • North America is expected to account for more
    than half the therapeutic drug monitoring market
    share in 2015. It is the prime market for
    therapeutic drug monitoring due to the high
    awareness and acceptance of the benefits of
    therapeutic drug monitoring and growing
    healthcare expenditure. The market in Europe on
    the other hand is growing at a slower rate as the
    healthcare sector is recovering from the economic
    downturn and healthcare facilities are trying to
    minimize healthcare delivery costs. Growth in the
    APAC therapeutic drug monitoring market is
    comparatively slower due to dearth of skilled
    healthcare personnel performing therapeutic drug
    monitoring tests with minimal errors.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
10
  • Major players in the therapeutic drug monitoring
    market include F. Hoffmann-La Roche AG
    (Switzerland), Siemens Healthcare (Germany),
    Thermo Fisher Scientific (U.S.), Bio-Rad
    Laboratories Inc. (U.S.), and Danaher Corporation
    (U.S.).

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
11
Contact Us
Contact Mr. Rohan Markets and Markets UNIT no
802, Tower no. 7, SEZ Magarpatta city,
Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441 Email sales_at_marketsandmarket
s.com
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
12
About MarketsandMarkets
MarketsandMarkets is the a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
About PowerShow.com